Sensipar — Class II drug recall D-0614-2026
Ongoing recall by Amgen, Inc., reported 2026-07-01, distributed nationwide. CGMP Deviations
| Recall number | D-0614-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Amgen, Inc., Thousand Oaks, CA, United States |
| Recall initiated | 2026-06-04 |
| Classified | 2026-06-23 |
| Reported by FDA | 2026-07-01 |
| Distributed | Nationwide (US) |
| Reason classes | cgmp |
| NDC | 55513-0073, 55513-0073-30, 55513-0074, 55513-0074-30, 55513-0075, 55513-0075-30 |
| Lot numbers | 1157055 |
| Expiration dates | 2028-01-31 |
Product
Sensipar (cinacalcet) Tablets, 60mg, 30-count bottles, Rx Only, Distributed by: Amge, One Amgen Center Drive, Thousand Oaks ,CA 91320-1799, Made in Japan. NDC 55513-074-30
Reason for recall
CGMP Deviations
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0614-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.